How big is the Global Nuclear Medicine Market?

The Global Nuclear Medicine Market size is expected to reach USD 15.54 billion in 2024 and grow at a CAGR of 12.14% to reach USD 27.56 billion by 2029. Read More

What is the current Global Nuclear Medicine Market size?

In 2024, the Global Nuclear Medicine Market size is expected to reach USD 15.54 billion. Read More

Who are the key players in Global Nuclear Medicine Market?

GE Healthcare, Curium, Novartis AG (Advanced Accelerator Applications), Cardinal Health Inc. and LANTHEUS HOLDINGS, INC are the major companies operating in the Global Nuclear Medicine Market. Read More

Which is the fastest growing region in Global Nuclear Medicine Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Nuclear Medicine Market?

In 2024, the North America accounts for the largest market share in Global Nuclear Medicine Market. Read More

What years does this Global Nuclear Medicine Market cover, and what was the market size in 2023?

In 2023, the Global Nuclear Medicine Market size was estimated at USD 13.65 billion. The report covers the Global Nuclear Medicine Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Global Nuclear Medicine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Nuclear Medicine Market Share

Statistics for the 2023 & 2024 Global Nuclear Medicine market share, created by Mordor Intelligence™ Industry Reports. Global Nuclear Medicine share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Nuclear Medicine Industry

The nuclear medicine market is moderately consolidated in nature. There is high competition among the players in the global nuclear medicine market. However, this competition is not by competitive pricing but by product differentiation. Additionally, big players in the pharmaceutical and biotechnology industries are leveraging their huge capital reserves to venture into this market, which is further increasing the competition. Major players in the market include GE Healthcare, Lantheus Medical Imaging, Novartis AG, Cardinal Health Inc., and Curium.